About Proteon Pharmaceuticals India Private Limited
Data last updated:
Proteon Pharmaceuticals India Private Limited is a foreign private limited company based in Thane, Maharashtra, India, a subsidiary of Proteon Pharmaceuticals S.A. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2017FTC303373. Its GSTIN is 27AAGCV2307L1Z6 (Maharashtra). The company holds 5 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹15.5 Cr and a paid-up capital of ₹14.51 Cr. It was formerly known as Vetphage Pharmaceuticals Private Limited and Proteon India Private Limited. It is led by directors including Arkadiusz Jozef Wojtasik and Pradnya Raju Wakle.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.17 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net loss of ₹5.57 Cr (net margin -256.6%) and EBITDA of -₹4.26 Cr (EBITDA margin -196.5%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 112% over five years.
The company has about 14 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Proteon Pharmaceuticals.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website proteonpharma.com.
Company details
Name history
Proteon Pharmaceuticals India has undergone 2 name changes throughout its history. The company was previously known as Vetphage Pharmaceuticals Private Limited, and Proteon India Private Limited. The current legal name is Proteon Pharmaceuticals India Private Limited.
| Company Name | Status |
|---|---|
| Proteon Pharmaceuticals India Private Limited | Current |
| Vetphage Pharmaceuticals Private Limited | Previous |
| Proteon India Private Limited | Previous |
Contact details
Proteon Pharmaceuticals India Private Limited's registered office is in Thane, Maharashtra. Its website is proteonpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address11th Floor Flat 1110 Fortune Emporio Mahajanwadi Penkarpada, Near Western Express Highway Opp Thakur Mall Mira Road (E), Thane, Maharashtra, India – 401107
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Proteon Pharmaceuticals India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Proteon Pharmaceuticals India operates one associated brand: Proteon Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Therapeutics for animal infectious diseases are developed via phage platforms. | proteonpharma.com |
Business activity
The main business activity of Proteon Pharmaceuticals India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Proteon Pharmaceuticals India Private Limited, buy the company report.
Financials of Proteon Pharmaceuticals India Private Limited
FY 2024 filings availableProteon Pharmaceuticals India Private Limited reported revenue of ₹2.17 Cr (down 11% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 11% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 112%. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4.26 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5.57 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -196.5% | ||||
| Net Profit Margin | -256.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Proteon Pharmaceuticals India Private Limited, buy the company report.
Board of directors of Proteon Pharmaceuticals India Private Limited
Proteon Pharmaceuticals India has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arkadiusz Jozef Wojtasik | Director | 15 Aug 2024 | 2 Years 2 Months | Current |
| Pradnya Raju Wakle | Director | 09 May 2024 | 2 Years 5 Months | Current |
| Marcio Caparroz Lopes Pinheiro | Director | 20 Jul 2024 | 2 Years 3 Months | Current |
Peer comparison
Proteon Pharmaceuticals India Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| VMG Pharmaceuticals Private Limited | ₹2.17 Cr (FY 2025) | -64.0% | Gurugram, Haryana, India | |||
| Lancer Drugs and Pharmaceuticals India Private Limited | ₹2.17 Cr (FY 2016) | 44.0% | Kochi, Kerala, India | |||
| Adore Lifescience Private Limited | ₹2.17 Cr (FY 2024) | -23.0% | Baddi, Himachal Pradesh, India | |||
| Proteon Pharmaceuticals India Private Limitedthis company | ₹2.17 Cr (FY 2024) | -₹5.57 Cr | -256.6% | -11.0% | 14 | Thane, Maharashtra, India |
| Jiwadaya Healthcare Private Limited | ₹2.17 Cr (FY 2025) | -15.0% | Mumbai, Maharashtra, India | |||
| Saanvi Pharmachem Private Limited | ₹2.16 Cr (FY 2024) | 2.0% | Moradabad, Uttar Pradesh, India |
To see the full peer comparison of Proteon Pharmaceuticals India Private Limited, buy the company report.
Auditor
Proteon Pharmaceuticals India Private Limited is audited by PRNAM & Associates LLP for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRNAM & Associates LLP | FY 2021 | 108701W/W100119 |
Shareholding
The shareholding of Proteon Pharmaceuticals India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Proteon Pharmaceuticals India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Proteon Pharmaceuticals India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Proteon Pharmaceuticals India Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2020, listing 1 overdue payment to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Prnam & Associates & LLP |
To see the full MSME payment records of Proteon Pharmaceuticals India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Proteon Pharmaceuticals India Private Limited has a workforce of 14 employees on its EPFO records as of Apr 10, 2024, across 1 active EPFO establishment.
GST
Proteon Pharmaceuticals India has 5 GST registrations: 4 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCV2307L1Z6 | Maharashtra | Active | 27 Jul 2018 |
| 19AAGCV2307L1Z3 | West Bengal | Active | 24 Sep 2020 |
| 36AAGCV2307L1Z7 | Telangana | Active | 25 Nov 2021 |
| 23AAGCV2307L1ZE | Madhya Pradesh | Active | 24 Jul 2023 |
To see the full GST registrations and return filing status of Proteon Pharmaceuticals India Private Limited, buy the company report.
Recent activity
Proteon Pharmaceuticals India Private Limited has 11 board changes on record since 2020: 3 appointments and 8 cessations. The latest: Arkadiusz Jozef Wojtasik ceased to be Additional Director on 29 Sep 2024.
2 earlier events are in the company report.
News
Frequently asked questions
Proteon Pharmaceuticals India is an active foreign private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 December 2017 (9+ years old) and is registered under CIN U74999MH2017FTC303373.
Proteon Pharmaceuticals India has 3 current directors:
- Arkadiusz Jozef Wojtasik - Director
- Pradnya Raju Wakle - Director
- Marcio Caparroz Lopes Pinheiro - Director
The latest financial statements of Proteon Pharmaceuticals India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Proteon Pharmaceuticals India is 27AAGCV2307L1Z6, registered in Maharashtra. The company has 5 GST registrations in all, of which 4 are active and 1 is cancelled or inactive. Other active GSTINs include 19AAGCV2307L1Z3 (West Bengal), 36AAGCV2307L1Z7 (Telangana), 23AAGCV2307L1ZE (Madhya Pradesh).
The CIN (Corporate Identification Number) of Proteon Pharmaceuticals India is U74999MH2017FTC303373. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Proteon Pharmaceuticals India was incorporated on 27 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Proteon Pharmaceuticals India by revenue are VMG Pharmaceuticals Private Limited, Lancer Drugs and Pharmaceuticals India Private Limited, Adore Lifescience Private Limited, Jiwadaya Healthcare Private Limited, Saanvi Pharmachem Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Arkadiusz Jozef Wojtasik ceased to be Additional Director on 29 Sep 2024. Marcio Caparroz Lopes Pinheiro ceased to be Additional Director on 29 Sep 2024. Pradnya Raju Wakle ceased to be Additional Director on 29 Sep 2024. Proteon Pharmaceuticals India has 11 board changes on record in total.
Proteon Pharmaceuticals India has 1 MSME Form 1 return on record for the period ending Mar 2020, listing 1 overdue payment to 1 micro and small supplier. The latest return was filed on 03 Oct 2020.
Proteon Pharmaceuticals India can be reached through the website proteonpharma.com. Its registered office is in Thane, Maharashtra, India.
The registered office of Proteon Pharmaceuticals India is at 11th Floor Flat 1110 Fortune Emporio Mahajanwadi Penkarpada, Near Western Express Highway Opp Thakur Mall Mira Road E, Thane, Maharashtra, India – 401107.
Proteon Pharmaceuticals India operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
